Development and validation of a uric acid-inflammation-metabolism score for predicting osteoarthritis risk: evidence from NHANES 2007–2018 and an external Chinese cohort - Scorecard - MDSpire
Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Creation and assessment of a Uric Acid-Inflammation-Metabolism score for predicting the likelihood of osteoarthritis: findings from NHANES 2007–2018 and a validation cohort from China
Clinical Scorecard: Creation and assessment of a Uric Acid-Inflammation-Metabolism score for predicting the likelihood of osteoarthritis: findings from NHANES 2007–2018 and a validation cohort from China
At a Glance
Category
Detail
Condition
Key Mechanisms
Uric acid metabolism, inflammatory status, metabolic disturbance and their interactions
Target Population
Care Setting
Key Highlights
Significant J-shaped nonlinear relationship observed, indicating varying OA risk at different UIM score levels
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Regularly evaluate UIM score components in at-risk populations, ideally every 6-12 months
Risks
Patient & Prescribing Data
Focus on managing uric acid levels, inflammation, and metabolic syndrome components, including dietary changes and pharmacotherapy
Clinical Best Practices
Consider lifestyle interventions targeting obesity and metabolic syndrome, supported by recent studies
A Geneva registry study points surgeons toward residual pain over functional limitation as the outcome that tracks patient satisfaction one year after hip or knee replacement.
